TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6368946

Group type: EXPERIMENTAL
Intervention: Essential amino acid/keto acid mixture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KMVA (keto‐isoleucine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KIVA (keto‐valine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KICA (keto‐leucine)
Number of subjects: 0
Study: 31924275

Group type: EXPERIMENTAL
Intervention: SES-sensitive implementation strategy (blended care format with GP nurse guidance)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Regular implementation strategy
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Monitoring and evaluating psychological complaints (depression, sleep, stress, worry, anxiety) and well-being
Number of subjects: 228
Study: 30980680

Group type: EXPERIMENTAL
Intervention: Carbapenem administration before or during chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No carbapenem administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abundance of Blautia in fecal microbiota
Number of subjects: 0
Study: 28446297

Group type: EXPERIMENTAL
Intervention: High-dose intravenous mecobalamin (HDIME)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Bortezomib-based chemotherapy (Control)
Number of subjects: 65
Study: 25502222

Group type: EXPERIMENTAL
Intervention: Better Futures model (Summer Institute, individual peer coaching, mentoring workshops)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Better Futures model
Number of subjects: 67

Group type: COMPARATOR
Intervention: Typical services (control group)
Number of subjects: 67
Study: 24345428

Group type: EXPERIMENTAL
Intervention: Long-acting dihydrocodeine tablets (DHC-Continus)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Short-acting dihydrocodeine tablets
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 22943608

Group type: EXPERIMENTAL
Intervention: Radiotherapy group (surgical treatment + adjuvant radiotherapy)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (surgical treatment only)
Number of subjects: 62
Study: 19954047

Group type: EXPERIMENTAL
Intervention: Intravenous levofloxacin 500 mg once a day
Number of subjects: 4888
Study: 17295714

Group type: EXPERIMENTAL
Intervention: Decompression/stabilization operation in the cervical spine: the Smith/Robinson operation
Number of subjects: 32
Study: 15029333

Group type: EXPERIMENTAL
Intervention: Selective testing group (no preoperative testing unless new or worsening medical problem)
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Routine testing group (12-lead electrocardiogram, complete blood count, serum glucose level)
Number of subjects: 1025
Study: 11298222

Group type: EXPERIMENTAL
Intervention: Retrospective report style with schema consistent information
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Retrospective report style with schema inconsistent information
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Prospective report style with schema consistent information
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Prospective report style with schema inconsistent information
Number of subjects: 48

Group type: COMPARATOR
Intervention: Any report style
Number of subjects: 48
Study: 9207281

Group type: EXPERIMENTAL
Intervention: Etidronate (400 mg/day during 14 days every 3 months)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Fluoride (50 mg/day, enteric-coated tablets)
Number of subjects: 32
Study: 8434331

Group type: EXPERIMENTAL
Intervention: High-intensity, dynamic back extension and abdominal exercises with occurrence of low back pain being the limiting factor
Number of subjects: 96

Group type: COMPARATOR
Intervention: Traditional program of mild, generally mobility‐improving exercises within pain limits
Number of subjects: 96
Study: 3121288

Group type: EXPERIMENTAL
Intervention: Ensure (hourly)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ensure (4-hourly)
Number of subjects: 8

Group type: COMPARATOR
Intervention: PHT without Ensure (A)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: PHT with Ensure (hourly) (B)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: PHT with Ensure (4-hourly) (C)
Number of subjects: 8
Study: 29582543

Group type: EXPERIMENTAL
Intervention: Non-operative caries treatment programme based on the Nexø method (NOCTP)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Care as usual plus 2 extra professional fluoride applications (IPFA)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Care as usual (CONTROL)
Number of subjects: 106
Study: 27304677

Group type: EXPERIMENTAL
Intervention: Adventurous Dreaming Highflying Dragon
Number of subjects: 73

Group type: COMPARATOR
Intervention: Comparable full-body-driven game without ADHD-focused training components
Number of subjects: 73
Study: 25413071

Group type: EXPERIMENTAL
Intervention: Urokinase after 3 days of indwelling catheter
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (urokinase after onset of catheter dysfunction)
Number of subjects: 38
Study: 23724615

Group type: EXPERIMENTAL
Intervention: Topical calcipotriol and betamethasone dipropionate (combined regimen) for 4 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical betamethasone valerate (monotherapy) for 4 weeks
Number of subjects: 50
Study: 20681233

Group type: EXPERIMENTAL
Intervention: Chronic nocturnal sleep restriction (4 h/d for 8 days)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Time of day (0800 vs 1800)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Diurnal nap (part of the 18 schedules)
Number of subjects: 90
Study: 18027038

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg i.v.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: granisetron 3 mg i.v.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: dexamethasone 8 mg i.v.
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.9% NaCl (placebo)
Number of subjects: 80
Study: 16822135

Group type: EXPERIMENTAL
Intervention: Resonance frequency as the stimulus dimension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duration as the stimulus dimension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New categorization model combining aspects of decision-bound and distribution theories
Number of subjects: 0
Study: 12819249

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 124
Study: 10792122

Group type: EXPERIMENTAL
Intervention: Oral magnesium sulphate (MgSO4)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9094893

Group type: EXPERIMENTAL
Intervention: 30 mg Fe once weekly
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: 30 mg Fe once weekly with anthelminthic treatment
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study: 8194433

Group type: EXPERIMENTAL
Intervention: Simvastatin 10‐40mg/day (mean 17.9mg/day)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Gemfibrozil 1200mg/day
Number of subjects: 59
Study: 3465753

Group type: EXPERIMENTAL
Intervention: Double-headed toothbrush
Number of subjects: 34

Group type: COMPARATOR
Intervention: Single-headed toothbrush
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both toothbrushes
Number of subjects: 34
Study: 28919067

Group type: EXPERIMENTAL
Intervention: Hepcidin quantification and treatment based on hepcidin levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional ferritin methods for diagnosing ID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hepcidin treatment recommendations: IV iron when hepcidin <20μg/L; IV iron + erythropoietin when hepcidin 20-41μg/L
Number of subjects: 0
Study: 25755063

Group type: EXPERIMENTAL
Intervention: HP-BMCs (hypoxia-preconditioned bone marrow mononuclear cells)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: N-BMCs (normoxia bone marrow mononuclear cells)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HP-BMCs
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: N-BMCs
Number of subjects: 36
Study: 23943134

Group type: EXPERIMENTAL
Intervention: Book‐supported primary prevention program 'Dominique's Handy Tricks'
Number of subjects: 46
Study: 21727253

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Waiting-list control (WLC)
Number of subjects: 117
Study: 19827103

Group type: EXPERIMENTAL
Intervention: Group psychotherapy (empowerment group)
Number of subjects: 51
Study: 17074548

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 2019

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2019
Study: 14715857

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 11440284

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/HCTZ 12.5 mg
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg/HCTZ 12.5 mg
Number of subjects: 818
Study: 9505800

Group type: EXPERIMENTAL
Intervention: Ready-to-feed soya formula with native phytic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spray-dried soya formula with 110 mg ascorbic acid/l
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Milk-based formula
Number of subjects: 0
Study: 8117220

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 3076136

Group type: EXPERIMENTAL
Intervention: Pinacidil
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 8
Study: 1441871

Group type: EXPERIMENTAL
Intervention: Mepivacaine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Mepivacaine + Ornipressin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Prilocaine
Number of subjects: 18
Study: 834800

Group type: EXPERIMENTAL
Intervention: 71 dB clicks presented in stimulus sequences consisting of a single click and a pair of clicks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Similar sequences of clicks with soft single clicks and loud pairs of clicks
Number of subjects: 12
Study: 30928681

Group type: EXPERIMENTAL
Intervention: Healthy Body Image (HBI) intervention
Number of subjects: 2446

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2446
Study: 28183318

Group type: EXPERIMENTAL
Intervention: Multi-modal early oral nutrition (EON)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 107
Study: 26485460

Group type: EXPERIMENTAL
Intervention: Integrated Hemodynamic Management (IHM)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 167
Study: 23807067

Group type: EXPERIMENTAL
Intervention: Healthcare delivery preferences
Number of subjects: 3611

Group type: EXPERIMENTAL
Intervention: Healthcare visits
Number of subjects: 3611

Group type: EXPERIMENTAL
Intervention: Healthcare delivery concerns
Number of subjects: 3611

Group type: EXPERIMENTAL
Intervention: Co-located gynecology with general healthcare
Number of subjects: 3611

Group type: EXPERIMENTAL
Intervention: Integration and coordination of care
Number of subjects: 3611
Study: 21813428

Group type: EXPERIMENTAL
Intervention: Narrative exposure therapy (n = 29)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Academic catch-up program with elements of supportive counseling (n = 28)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Waiting list (n = 28)
Number of subjects: 85
Study: 20139566

Group type: EXPERIMENTAL
Intervention: Three‐step etch‐and‐rinse (Adper Scotchbond Multi‐Purpose, 3M ESPE‐SBMP)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Two‐step etch‐and‐rinse (Adper Single Bond 2, 3 M ESPE‐SB)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Two‐step self‐etch (AdheSE, Ivoclar/Vivadent‐AD)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Self‐etch 1 step (Adper Prompt L‐Pop, 3M ESPE‐LP)
Number of subjects: 24
Study: 16912024

Group type: EXPERIMENTAL
Intervention: delapril 30 mg twice daily
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: delapril 15 mg twice daily
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: delapril 30 mg once daily
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: delapril 7.5 mg twice daily
Number of subjects: 303

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: delapril
Number of subjects: 303
Study: 14685864

Group type: EXPERIMENTAL
Intervention: Self-paced household tasks (sweeping, window cleaning, vacuuming, mowing)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Home environment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Laboratory environment
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Energy expenditure prediction
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Household chores
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Self-paced energy expenditure
Number of subjects: 36
Study: 11246578

Group type: EXPERIMENTAL
Intervention: High work-related stress (highest stress quintile)
Number of subjects: 467

Group type: COMPARATOR
Intervention: Low work-related stress (lowest stress quintile)
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Work-related stress in women
Number of subjects: 467
Study: 9885118

Group type: EXPERIMENTAL
Intervention: Early extubation after cardiac surgery
Number of subjects: 266
Study: 7993326

Group type: EXPERIMENTAL
Intervention: Inhalation of 5, 10, and 20% carbon dioxide (CO2)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Inhalation of room air
Number of subjects: 49
Study: 2701745

Group type: EXPERIMENTAL
Intervention: Buspirone (BUS, 10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diazepam (DZP, 10 mg)
Number of subjects: 12
Study: 30715255

Group type: EXPERIMENTAL
Intervention: Thoracoscopic ablation
Number of subjects: 124

Group type: COMPARATOR
Intervention: Catheter ablation
Number of subjects: 124
Study: 28847326

Group type: EXPERIMENTAL
Intervention: Scrub 1 (scrubs with a complex element compound with a silver-alloy embedded in its fibers)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Scrub 2 (scrubs impregnated with an organosilane-based quaternary ammonium and a hydrophobic fluoroacrylate copolymer emulsion)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (standard cotton-polyester surgical scrubs)
Number of subjects: 40
Study: 26096109

Group type: EXPERIMENTAL
Intervention: Topical ozone therapy
Number of subjects: 40
Study: 23500091

Group type: EXPERIMENTAL
Intervention: Fulvestrant 250 mg IM every 4 weeks
Number of subjects: 35
Study: 21396763

Group type: EXPERIMENTAL
Intervention: Suctioning via the endotracheal tube during laryngoscopy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard intubation strategy with suctioning using a separate catheter
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Suctioning via the endotracheal tube
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard intubation strategy
Number of subjects: 41
Study: 18438122

Group type: EXPERIMENTAL
Intervention: Imprint cytology for intraoperative diagnosis of sentinel node metastases
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Imprint cytology positive results
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Need for second axillary operation
Number of subjects: 631
Study: 16792615

Group type: EXPERIMENTAL
Intervention: C-Trach
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: McCoy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: ILMA
Number of subjects: 90
Study: 12615021

Group type: EXPERIMENTAL
Intervention: Bulk filling technique (G7 and G8)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Incremental filling techniques (G1, G2, G3, G4, G5, G6)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-viscosity composite liner (Tetric Flow Chroma)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (flat dentin surfaces, G9 and G10)
Number of subjects: 10
Study: 11550733

Group type: EXPERIMENTAL
Intervention: Hypnotic-relaxation training
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no hypnotic-relaxation training)
Number of subjects: 33
Study: 9593133

Group type: EXPERIMENTAL
Intervention: 1,000 mg of sulbactam with 2,000 mg of ampicillin by intravenous bolus injection (3 min), repeated after 2 hours.
Number of subjects: 16

Group type: COMPARATOR
Intervention: 1,000 mg of sulbactam with 2,000 mg of ampicillin by bolus injection (3 min) followed by a continuous infusion of the same dose over 4 hours.
Number of subjects: 16
Study: 8112244

Group type: EXPERIMENTAL
Intervention: Carbamazepine-CR (CBZ-CR) 20 mg/kg as a single loading dose
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) 20 mg/kg (two-thirds at 0 h and one-third at 2 h)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Carbamazepine-CR and Phenytoin
Number of subjects: 42
Study: 3293400

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 3234

Group type: COMPARATOR
Intervention: Thiazide diuretic
Number of subjects: 3234
Study: 30397934

Group type: EXPERIMENTAL
Intervention: TeenPower mHealth programme (Group A: with structured school-based intervention; Group B: only mHealth programme)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Structured school-based intervention programme (Control group)
Number of subjects: 0
Study: 27718000

Group type: EXPERIMENTAL
Intervention: bosutinib with aprepitant (125 mg × 1)
Number of subjects: 19

Group type: COMPARATOR
Intervention: bosutinib alone (100 mg × 5)
Number of subjects: 19
Study: 26576497

Group type: EXPERIMENTAL
Intervention: Subpleural analgesia (SPA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 30
Study: 25380241

Group type: EXPERIMENTAL
Intervention: BV 1 treatment (1:10,000 concentration BVA plus physiotherapy)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: BV 2 treatment (1:30,000 concentration BVA plus physiotherapy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control treatment (normal saline injection plus physiotherapy)
Number of subjects: 60
Study: 22466026

Group type: EXPERIMENTAL
Intervention: Training group (20 minutes of daily postural and movement activities for 4 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (social interaction for 4 weeks)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 22
Study: 18583515

Group type: EXPERIMENTAL
Intervention: Automatic analysis of saturation and respiratory signal (automatic RDI [RDIa] and automatic desaturation index of 3% [DI3%a])
Number of subjects: 218

Group type: COMPARATOR
Intervention: Visual respiratory disturbance index (RDI)
Number of subjects: 218
Study: 17601465

Group type: EXPERIMENTAL
Intervention: Individualized education and structured telephone counseling follow-up
Number of subjects: 150

Group type: COMPARATOR
Intervention: Customary care
Number of subjects: 150
Study: 15353542

Group type: EXPERIMENTAL
Intervention: Intensive postremission chemotherapy
Number of subjects: 922

Group type: COMPARATOR
Intervention: Less intensive postremission chemotherapy
Number of subjects: 922

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Autologous SCT
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Allogeneic SCT
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Standard four-drug/4-week induction course
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: HLA-matched sibling transplant
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Philadelphia chromosome-positive ALL
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: CNS-positive ALL
Number of subjects: 922
Study: 11594640

Group type: EXPERIMENTAL
Intervention: Increased intensity of rehabilitation therapy input without change in content
Number of subjects: 56

Group type: COMPARATOR
Intervention: Routine therapy
Number of subjects: 56
Study: 9657471

Group type: EXPERIMENTAL
Intervention: Cutting Balloon angioplasty
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty
Number of subjects: 64
Study: 10829905

Group type: EXPERIMENTAL
Intervention: FT‐AGA with asphyxia (n = 15)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: FT‐IUGR with asphyxia (n = 10)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: PT‐AGA with asphyxia (n = 10)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Bicarbonate-treated asphyxiated infants
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control infants (without asphyxia)
Number of subjects: 72
Study: 2144208

Group type: EXPERIMENTAL
Intervention: Zoladex 3.6 mg as a depot preparation combined with flutamide 250 mg tid
Number of subjects: 591

Group type: COMPARATOR
Intervention: Orchiectomy
Number of subjects: 591
Study: 364923

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 28
Study: 30536932

Group type: EXPERIMENTAL
Intervention: Nurse-led sleep programme (4 weekly 1-hr sessions)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Regular nursing home services
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Nurse-led sleep programme
Number of subjects: 52
Study: 27153860

Group type: EXPERIMENTAL
Intervention: Actual power
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Achieved power
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Attempted power
Number of subjects: 270
Study: 25928315

Group type: EXPERIMENTAL
Intervention: Tailored knowledge acquisition intervention
Number of subjects: 1159

Group type: COMPARATOR
Intervention: Nontailored control
Number of subjects: 1159
Study: 23601796

Group type: EXPERIMENTAL
Intervention: Isotonic balanced solutions (crystalloid and hydroxyethyl starch; balanced group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Isotonic sodium chloride solutions (crystalloid and hydroxyethyl starch; saline group)
Number of subjects: 42
Study: 21409399

Group type: EXPERIMENTAL
Intervention: copy‐typing (typing)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: typing at progressively faster speed (pacing)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: mental arithmetic plus fast typing (subtraction)
Number of subjects: 14

Group type: COMPARATOR
Intervention: rest periods
Number of subjects: 14

Group type: COMPARATOR
Intervention: baseline
Number of subjects: 14
Study: 18620827

Group type: EXPERIMENTAL
Intervention: Endo-extralaryngeal needle carrier (EENC)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Non-EENC
Number of subjects: 11
Study: 18236999

Group type: EXPERIMENTAL
Intervention: Montelukast (oral)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25